BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 23, 2026
Home » Authors » Lynn Yoffee

Articles by Lynn Yoffee

Transplant medicine advances from a cooler of ice to LifePort

Jan. 5, 2009
By Lynn Yoffee
Just as the new year begins, researchers have pushed open a massive door in the field of organ transplantation medicine that will offer expanded opportunities for more transplants with far better outcomes. (Medical Device Daily)
Read More

MITA asserts 'value of imaging' as key part of healthcare reform

Dec. 31, 2008
By Lynn Yoffee
Just as a slew of other organizations have done, in anticipation of a new administration, the Medical Imaging and Technology Alliance (MITA; Rosslyn, Virginia) last week pledged its support for healthcare reform intended to provide all Americans with access to affordable, quality healthcare. And it lauded President–elect Barack Obama's renewed focus on health reform. (Diagnostics & Imaging Week
Read More

MRI can accurately ID early stages of Alzheimer's disease

Dec. 31, 2008
By Lynn Yoffee

MRI can accurately ID early stages of Alzheimer's disease

Dec. 30, 2008
By Lynn Yoffee

Edwards CEO: Disclosure of payments a 'challenge' for some

Dec. 29, 2008
By Lynn Yoffee

MITA asserts 'value of imaging' as key part of healthcare reform

Dec. 24, 2008
By Lynn Yoffee

CABANA registry launched for Boston Sci carotid stent

Dec. 22, 2008
By Lynn Yoffee
Less than two months after FDA approval of Boston Scientific's (Natick, Massachusetts) Carotid Wallstent Monorail Endoprosthesis for patients with carotid artery disease who are at high risk for surgery, the first patient has been enrolled in a 1,000-patient surveillance registry. (Medical Device Daily)
Read More

Abbott starts trial of Xience stent for smaller vessels

Dec. 19, 2008
By Lynn Yoffee
Physicians have been limited in their efforts to treat coronary artery disease in narrower vessels. Abbott (Abbott Park, Illinois) is seeking to fill that treatment gap, which accounts for about 10% of all procedures to treat lesions, with the start of a trial evaluating a 2.25 mm size of the Xience V everolimus eluting coronary stent system. (Medical Device Daily)
Read More

IOM calls for major refocus at HHS as Daschle takes helm

Dec. 18, 2008
By Lynn Yoffee
The U.S. Department of Health and Human Services (HHS) — which has the largest budget of any federal department, spending a whopping $2 billion per day — is being advised by the Institute of Medicine (IOM; Washington) to review, revamp and rechart a new course for healthcare in America. (Medical Device Daily)
Read More

Private sector picks up tab left by Medicare, Medicaid

Dec. 17, 2008
By Lynn Yoffee
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 50 51 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 22, 2026.
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing